These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 18377389)
21. From the editorial office. Rothrock JF Headache; 2012; 52(7):1069. PubMed ID: 22755549 [No Abstract] [Full Text] [Related]
22. Drug interactions with triptans : which are clinically significant? Rolan PE CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546 [TBL] [Abstract][Full Text] [Related]
23. The serotonin syndrome. Boyer EW; Shannon M N Engl J Med; 2005 Mar; 352(11):1112-20. PubMed ID: 15784664 [No Abstract] [Full Text] [Related]
24. Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessary. Horn JR; Hansten PD J Manag Care Pharm; 2011 Nov; 17(9):713. PubMed ID: 22050397 [No Abstract] [Full Text] [Related]
30. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823 [TBL] [Abstract][Full Text] [Related]
31. Successful treatment of serotonin syndrome with chlorpromazine. Gillman PK Med J Aust; 1996 Sep; 165(6):345-6. PubMed ID: 8862337 [No Abstract] [Full Text] [Related]
32. Is an FDA alert harming patients? Schuman E JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393 [No Abstract] [Full Text] [Related]
33. Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy. Karkow DC; Kauer JF; Ernst EJ J Clin Psychopharmacol; 2017 Oct; 37(5):518-523. PubMed ID: 28796019 [TBL] [Abstract][Full Text] [Related]
34. Drug-induced serotonin syndrome: a review. Sun-Edelstein C; Tepper SJ; Shapiro RE Expert Opin Drug Saf; 2008 Sep; 7(5):587-96. PubMed ID: 18759711 [TBL] [Abstract][Full Text] [Related]
35. The serotonin syndrome, triptans, and the potential for drug-drug interactions. Shapiro RE; Tepper SJ Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366 [TBL] [Abstract][Full Text] [Related]
36. Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists. Huang V; Gortney JS Pharmacotherapy; 2006 Dec; 26(12):1784-93. PubMed ID: 17125439 [TBL] [Abstract][Full Text] [Related]
37. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say? Kogut SJ J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895 [TBL] [Abstract][Full Text] [Related]
38. Serotonin syndrome: take a closer look at the unwell surgical patient. Shaikh ZS; Krueper S; Malins TJ Ann R Coll Surg Engl; 2011 Nov; 93(8):569-72. PubMed ID: 22041229 [TBL] [Abstract][Full Text] [Related]
39. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning? Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629 [No Abstract] [Full Text] [Related]